Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis

Oral Microbiol Immunol. 1994 Apr;9(2):123-5. doi: 10.1111/j.1399-302x.1994.tb00046.x.

Abstract

The antimicrobial susceptibilities of 81 recent clinical Porphyromonas gingivalis isolates and two reference strains were determined by the E test, a new method, and were compared with the minimal inhibitory concentrations for these strains obtained by the reference agar dilution method on supplemented Brucella blood agar. The following agreements were obtained: benzylpenicillin 100%, ampicillin 96%, cefaclor 82%, cefuroxime 91%, erythromycin 93%, clindamycin 99%, tetracycline 66%, doxycycline 89%, metronidazole 77% and ciprofloxacin 77%. Very major discrepancies were observed with ciprofloxacin. This study indicates that the E test is an acceptable method to determine the susceptibility of P. gingivalis for most antimicrobials.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ampicillin / pharmacology
  • Anti-Bacterial Agents / pharmacology*
  • Cefaclor / pharmacology
  • Cefuroxime / pharmacology
  • Ciprofloxacin / pharmacology
  • Clindamycin / pharmacology
  • Colony Count, Microbial
  • Doxycycline / pharmacology
  • Erythromycin / pharmacology
  • Evaluation Studies as Topic
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests / methods*
  • Penicillin G / pharmacology
  • Porphyromonas gingivalis / drug effects*
  • Tetracyclines / pharmacology

Substances

  • Anti-Bacterial Agents
  • Tetracyclines
  • Metronidazole
  • Clindamycin
  • Ciprofloxacin
  • Erythromycin
  • Cefaclor
  • Ampicillin
  • Doxycycline
  • Cefuroxime
  • Penicillin G